Urologists at Vanderbilt Health are enrolling men with stress urinary incontinence (SUI) in a clinical trial named SOPHIA2 to ...

Japan has approved two stem cell-based therapies for treating Parkinson's disease and heart failure in a world first, through ...

High-grade gliomas, especially glioblastoma (GBM) and others, remain among the most aggressive brain cancers, with few ...

US-supported international HIV research, particularly that conducted in African countries, has direct benefits to Americans. Cuts to that research may undermine those benefits.

The South Jersey biotech also secured a $22 million ARPA-H grant and additional investment to advance its research on therapies targeting aging.

Researchers in Japan pioneered reprogrammed cells 20 years ago. Now the country has given the first-ever authorizations to manufacture and sell medical products based on the technology.

Fred Hutch Cancer Center medical oncologist Dr. Lisa Tachiki has been named a 2025 Cancer Research Fellow by the Kuni Foundation, an honor that includes an unrestricted, two-year $300,000 award.

With NIH funding, the group will pursue research and patient care approaches for a disease that affects more than 250 million people around the globe ...

Two pivotal Phase 3 trials of Haduvio are expected to launch this year and, if positive, may support applications seeking its approval.

Risankizumab showed high rates of clinical remission and endoscopic response when administered as subcutaneous induction therapy for moderate to severe CD.